Uncommon cold: Could 4°C storage improve platelet function?

Transfusion

Volumn 45, Issue 9, 2005, Pages 1407-1412

  Kaufman, Richard M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHAMBETA2 INTEGRIN; ASPARAGINE LINKED OLIGOSACCHARIDE; GALACTOSE; GALACTOSYLTRANSFERASE; N ACETYL BETA GLUCOSAMINIDASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOSE; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; BLOOD STORAGE; CELL VIABILITY; COVALENT BOND; HUMAN; HUMAN CELL; IN VIVO STUDY; ISOTOPE LABELING; LOW TEMPERATURE PROCEDURES; NOTE; RISK REDUCTION; ROOM TEMPERATURE; STORAGE TEMPERATURE; TECHNOLOGY; TEMPERATURE MEASUREMENT; THROMBOCYTE FUNCTION; CELL SURVIVAL; COLD; CYTOLOGY; METHODOLOGY; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

BLOOD PLATELETS; BLOOD PRESERVATION; CELL SURVIVAL; COLD; HUMANS; PLATELET TRANSFUSION;

EID: 26944443962     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.00544.x     Document Type: Note

References (67)

1. Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability - deleterious effect of refrigerated storage. N Engl J Med 1969;280:1094-8.
2. Becker GA, Tuccelli M, Kunicki T, et al. Studies of platelet concentrates stored at 22 C and 4 C. Transfusion 1973;13:61-8.
3. Slichter SJ, Harker LA. Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. Br J Haematol 1976;34:403-19.
4. Murphy S, Gardner FH. Platelet storage at 22 degrees C: metabolic, morphologic, and functional studies. J Clin Invest 1971;50:370-7.
5. Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell 2003;112:87-97.
6. Josefsson EC, Gebhard HH, Stossel TP, et al. The macrophage alphambeta2 integrin alphaM-lectin domain mediates the phagocytosis of chilled platelets. J Biol Chem 2005;280:18025-32.
7. Hoffmeister KM, Josefsson EC, Isaac NA, et al. Glycosylation restores survival of chilled blood platelets. Science 2003;301:1531-4.
8. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States: 1998 through 2000. Transfusion 2001;41:1493-9.
9. Currie LM, Harper JR, Allan H, Connor J. Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4 degrees C with retention of in vitro functional activity. Transfusion 1997;37:18-24.
10. Snyder EL, Rinder HM. Platelet storage - time to come in from the cold? N Engl J Med 2003;348:2032-3.
11. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005;18:195-204.
12. AuBuchon JP. Pathogen reduction technologies: what are the concerns? Vox Sang 2004;87(Suppl 2):84-9.
13. Corash L. Pathogen reduction technology: methods, status of clinical trials, and future prospects. Curr Hematol Rep 2003;2:495-502.
14. Murphy S, Rebulla P, Bertolini F, et al. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion. Transfus Med Rev 1994;8:29-36.
15. Guidance for industry for platelet testing and evaluation of platelet substitute products [Internet]. Rockville MD: Center for Biologics Evaluation and Research (CBER), Food and Drug Administration; 1999. p. 1-7. Available from: http://www.fda.gov/cber/gdlns/platelet.htm
16. Hersh EM, Bodey GP, Nies BA, Freireich EJ. Causes of death in acute leukemia: a ten-year study of 414 patients from 1954 to 1963. JAMA 1965;193:105-9.
17. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997;337:1870-5.
18. Wandt H, Frank M, Ehninger G, et al. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998;91:3601-6.
19. Chernoff A, Snyder EL. The cellular and molecular basis of the platelet storage lesion: a symposium summary. Transfusion 1992;32:386-90.
20. Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus Med Rev 1997;11:130-44.
21. Kunicki TJ, Tuccelli M, Becker GA, Aster RH. A study of variables affecting the quality of platelets stored at "room temperature." Transfusion 1975;15:414-21.
22. Snyder EL. Activation during preparation and storage of platelet concentrates. Transfusion 1992;32:500-2.
23. Rinder HM, Snyder EL, Bonan JL, et al. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion 1993;33:25-9.
24. Holme S. Storage and quality assessment of platelets. Vox Sang 1998;74(Suppl 2):207-16.
25. Bertino AM, Qi XQ, Li J, et al. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 2003;43:857-66.
26. AuBuchon JP, Herschel L, Roger J, Murphy S. Preliminary validation of a new standard of efficacy for stored platelets. Transfusion 2004;44:36-41.
27. Murphy S. What's so bad about old platelets? Transfusion 2002;42:809-11.
28. Dumont LJ, AuBuchon JP, Whitley P, et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002;42:847-54.
29. Haddad S. FDA approach to evaluating efficacy of platelet products. Baltimore: AABB Annual Meeting; 2004.
30. Rock G, Figueredo A. Metabolic changes during platelet storage. Transfusion 1976;16:571-9.
31. Slichter SJ. In vitro measurements of platelet concentrates stored at 4 and 22 degree C: correlation with posttransfusion platelet viability and function. Vox Sang 1981;40(Suppl 1):72-86.
32. Rinder HM, Snyder EL. Activation of platelet concentrate during preparation and storage. Blood Cells 1992;18:445-56;discussion 57-60.
33. Rinder HM, Ault KA. Platelet activation and its detection during the preparation of platelets for transfusion. Transfus Med Rev 1998;12:271-87.
34. Rinder HM, Murphy M, Mitchell JG, et al. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991;31:409-14.
35. Triulzi DJ, Kickler TS, Braine HG. Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion 1992;32:529-33.
36. Fijnheer R, Modderman PW, Veldman H, et al. Detection of platelet activation with monoclonal antibodies and flow cytometry: changes during platelet storage. Transfusion 1990;30:20-5.
37. Klinger MH, Mendoza AS, Kluter H, et al. Storage lesion of human platelets as revealed by ultrathin sections and freeze-fracture replicas. Cell Tissue Res 1994;276:477-83.
38. Snyder EL, Hezzey A, Katz AJ, Bock J. Occurrence of the release reaction during preparation and storage of platelet concentrates. Vox Sang 1981;41:172-7.
39. Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003;43:526-35.
40. Berger G, Hartwell DW, Wagner DD. P-selectin and platelet clearance. Blood 1998;92):4446-52.
41. Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 1996;93:11877-82.
42. Babic AH, Josefson EC, Kaufman RM, et al. Galactosylation inhibits in vitro phagocytosis of functionally active refrigerated human platelets obtained from standard platelet concentrates. Baltimore: AABB Annual Meeting; 2004.
43. Zucker MB, Borrelli J. Reversible alterations in platelet morphology produced by anticoagulants and by cold. Blood 1954;9:602-8.
44. Gousset K, Wolkers WF, Tsvetkova NM, et al. Evidence for a physiological role for membrane rafts in human platelets. J Cell Physiol 2002;190:117-28.
45. Gousset K, Tsvetkova NM, Crowe JH, Tablin F. Important role of raft aggregation in the signaling events of cold-induced platelet activation. Biochim Biophys Acta 2004;1660:7-15.
46. Valeri CR, Ragno G, Marks PW, et al. Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N,N′-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days. Transfusion 2004;44:865-70.
47. Italiano JE Jr, Bergmeier W, Tiwari S, et al. Mechanisms and implications of platelet discoid shape. Blood 2003;101:4789-96.
48. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998;38:31-40.
49. Shcherbina A, Remold-O'Donnell E. Role of caspase in a subset of human platelet activation responses. Blood 1999;93:4222-31.
50. Li J, Xia Y, Bertino AM, et al. The mechanism of apoptosis in human platelets during storage. Transfusion 2000;40:1320-9.
51. Choi JW, Pai SH. Influence of storage temperature on the responsiveness of human platelets to agonists. Ann Clin Lab Sci 2003;33:79-85.
52. McGill M, Brindley DC. Effects of storage on platelet reactivity to arterial subendothelium during blood flow. J Lab Clin Med 1979;94:370-80.
53. Shively JA, Gott CL, De Jongh DS. The effect of storage on adhesion and aggregation of platelets. Vox Sang 1970;18:204-15.
54. Rinder HM, Snyder EL, Tracey JB, et al. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival. Transfusion 2003;43:1230-7.
55. Blajchman MA, Lee DH. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes. Transfus Med Rev 1997;11:95-105.
56. Krishnamurti C, Maglasang P, Rothwell SW. Reduction of blood loss by infusion of human platelets in a rabbit kidney injury model. Transfusion 1999;39:967-74.
57. Rothwell SW, Maglasang P, Reid TJ, et al. Correlation of in vivo and in vitro functions of fresh and stored human platelets. Transfusion 2000;40:988-93.
58. Rothwell SW, Maglasang P, Krishnamurti C. Survival of fresh human platelets in a rabbit model as traced by flow cytometry. Transfusion 1998;38:550-6.
59. Handin RI, Valeri CR. Hemostatic effectiveness of platelets stored at 22 degrees C. N Engl J Med 1971;285:538-43.
60. Valeri CR. Circulation and hemostatic effectiveness of platelets stored at 4 C or 22 C: studies in aspirin-treated normal volunteers. Transfusion 1976;16:20-3.
61. Kattlove HE. Platelet preservation - what temperature? A rationale for strategy. Transfusion 1974;14:328-30.
62. Filip DJ, Aster RH. Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. J Lab Clin Med 1978;91:618-24.
63. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990;16:1-20.
64. Carr ME Jr. In vitro assessment of platelet function. Transfus Med Rev 1997;11:106-15.
65. Cazenave JP, Davis K, Corash L. Design of clinical trials to evaluate the efficacy of platelet transfusion: the euroSPRITE trial for components treated with Helinx technology. Semin Hematol 2001;38(4 Suppl 11):46-54.
66. van Rhenen D, Gulliksson H, Cazenave JP, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003;101:2426-33.
67. McCullough J, Vesole DH, Benjamin RJ, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004;104:1534-41.